ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p515.xmlNon–Small Cell Lung Cancer, Version 6.20152026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p515.pdf2026-04-18Non–Small Cell Lung Cancer, Version 6.2015https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p508.xmlSorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutation2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p508.pdf2026-04-18Sorafenib in Relapsed AML With FMS-Like Receptor Tyrosine Kinase-3 Internal Tandem Duplication Mutationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p501.xmlDefining Borderline Resectable Pancreatic Cancer: Emerging Consensus for an Old Challenge2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p501.pdf2026-04-18Defining Borderline Resectable Pancreatic Cancer: Emerging Consensus for an Old Challengehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p505.xmlThe Rodger Winn Award2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p505.pdf2026-04-18The Rodger Winn Awardhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p499.xmlReducing Costs by Changing Behavior—Really?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p499.pdf2026-04-18Reducing Costs by Changing Behavior—Really?https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-pxxvii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-pxxvii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-plv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-plv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p525.xmlUse of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p525.pdf2026-04-18Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Centerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p587.xmlBiologic Agents in the Management of Hodgkin Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p587.pdf2026-04-18Biologic Agents in the Management of Hodgkin Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p554.xmlHodgkin Lymphoma, Version 2.20152026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p554.pdf2026-04-18Hodgkin Lymphoma, Version 2.2015https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p531.xmlOmission of Adjuvant Therapy After Gastric Cancer Resection: Development of a Validated Risk Model2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p531.pdf2026-04-18Omission of Adjuvant Therapy After Gastric Cancer Resection: Development of a Validated Risk Modelhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p543.xmlDiagnostic Delays Are Common Among Patients With Hepatocellular Carcinoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p543.pdf2026-04-18Diagnostic Delays Are Common Among Patients With Hepatocellular Carcinomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p597.xmlContemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p597.pdf2026-04-18Contemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-pe37.xmlSystemic Therapy for Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-pe37.pdf2026-04-18Systemic Therapy for Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neckhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-pe29.xmlManagement of the Primary Tumor and Limited Metastases in Patients With Metastatic Pancreatic Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-pe29.pdf2026-04-18Management of the Primary Tumor and Limited Metastases in Patients With Metastatic Pancreatic Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p607.xmlThe Need for United States–Based Guidelines for Myeloproliferative Neoplasms2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5/article-p607.pdf2026-04-18The Need for United States–Based Guidelines for Myeloproliferative Neoplasmshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p643.xmlNew NCCN Guidelines: Smoking Cessation for Patients With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p643.pdf2026-04-18New NCCN Guidelines: Smoking Cessation for Patients With Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p646.xmlToward Less-Invasive Management of Early-Stage Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p646.pdf2026-04-18Toward Less-Invasive Management of Early-Stage Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p619.xmlAbstracts From the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p619.pdf2026-04-18Abstracts From the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p640.xmlNCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p640.pdf2026-04-18NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p629.xmlNCCN: 20 Years of Improving Patients' Lives2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p629.pdf2026-04-18NCCN: 20 Years of Improving Patients' Liveshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p611.xml20 Years of Advancing the Standard of Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p611.pdf2026-04-1820 Years of Advancing the Standard of Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p686.xmlManagement of Dermatologic Toxicities2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p686.pdf2026-04-18Management of Dermatologic Toxicitieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p676.xmlTargeted/Emerging Therapies for Metastatic Non–Small Cell Lung Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p676.pdf2026-04-18Targeted/Emerging Therapies for Metastatic Non–Small Cell Lung Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p682.xmlOptimizing Systemic Therapy Selection in Metastatic Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p682.pdf2026-04-18Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p673.xmlTreatment Options Expanding for Advanced Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p673.pdf2026-04-18Treatment Options Expanding for Advanced Melanomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p679.xmlKidney Cancer: Current and Novel Treatment Options2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p679.pdf2026-04-18Kidney Cancer: Current and Novel Treatment Optionshttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p649.xmlOptimizing Treatment of HER2-Positive Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p649.pdf2026-04-18Optimizing Treatment of HER2-Positive Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p655.xmlAdvanced Hormone-Sensitive Breast Cancer: Overcoming Resistance2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p655.pdf2026-04-18Advanced Hormone-Sensitive Breast Cancer: Overcoming Resistancehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p652.xmlEvolving Treatment Strategies for Triple-Negative Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p652.pdf2026-04-18Evolving Treatment Strategies for Triple-Negative Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p662.xmlUpdates to the Management of Chronic Lymphocytic Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p662.pdf2026-04-18Updates to the Management of Chronic Lymphocytic Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p666.xmlEmerging Treatment Options for B-Cell Lymphomas2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p666.pdf2026-04-18Emerging Treatment Options for B-Cell Lymphomashttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p670.xmlPrinciples of Immunotherapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p670.pdf2026-04-18Principles of Immunotherapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p659.xmlNCCN Roundtable:Value-Based Decision-Making at the Bedside2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p659.pdf2026-04-18NCCN Roundtable:Value-Based Decision-Making at the Bedsidehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-pe65.xmlAdditional Abstracts from the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-pe65.pdf2026-04-18Additional Abstracts from the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p690.xmlNew Treatment Options in Castration-Resistant Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p690.pdf2026-04-18New Treatment Options in Castration-Resistant Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p694.xmlMultiple Myeloma: New Uses for Available Agents, Excitement for the Future2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p694.pdf2026-04-18Multiple Myeloma: New Uses for Available Agents, Excitement for the Futurehttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p700.xmlMultidisciplinary Management of Pancreatic Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p700.pdf2026-04-18Multidisciplinary Management of Pancreatic Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p697.xmlTreatment Milestones in Chronic Myelogenous Leukemia: Stay the Course or Change Therapy?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/13/5S/article-p697.pdf2026-04-18Treatment Milestones in Chronic Myelogenous Leukemia: Stay the Course or Change Therapy?